Kiwi company Douglas Pharmaceuticals has won approval to sell its locally developed acne medication in the United States.
the Auckland-based company has been trying for a decade to break into the US acne medication market, currently worth about US$400 million ($494 million). Its new medication isotretinoin now has Food and Drug Administration (FDA) approval.
the company is New Zealand’s largest manufacturer of pharmaceuticals, specialises in immuno-suppression, central nervous system, oncology and dermatology products. it already sells to 35 countries, with an export turnover of $85m.
Director Jeff Douglas said in a statement that it was a huge breakthrough …